Large commercial aircraft imports nearly tripled in a single month — that is the sharpest signal in February 2026's U.S. import data. Across ten of the top-moving commodity categories, every single one posted an increase, pointing to broad-based front-loading activity that supply chain managers cannot afford to ignore.
Aircraft Deliveries Spike 191%
Imports of airplanes and other aircraft with an unladen weight exceeding 15,000 kg (HTS 880240) surged 190.56% month-over-month, rising from $423.5 million in January 2026 to $1.23 billion in February. That $807 million jump is the largest percentage gain among the top movers and almost certainly reflects a cluster of wide-body commercial deliveries arriving simultaneously.
For airlines and aircraft lessors, the timing is notable. Delivery backlogs at major manufacturers have been a persistent constraint, and a single month's spike of this magnitude often signals that previously delayed units are finally clearing customs. Expect this figure to normalize in subsequent months unless additional deferred deliveries are in the pipeline.
Pharmaceutical Imports Accelerate on Multiple Fronts
Three pharmaceutical and biochemical categories posted triple-digit percentage gains in February, collectively adding over $1.4 billion in import value compared to January. Mixed immunological products not in measured doses (HTS 300214) climbed 164.85%, from $386.3 million to $1.02 billion — a $636.8 million increase in a single month.
Nucleic acids, salts, and other heterocyclic compounds (HTS 293499) rose 174.05%, reaching $779.0 million from $284.3 million, adding $494.8 million. Hormones and related dosage-form products (HTS 300439) more than doubled, up 101.33% to $620.0 million from $307.9 million. Together, these moves suggest pharmaceutical manufacturers and distributors are aggressively building inventory — a pattern consistent with companies hedging against potential tariff escalation on drug imports.
Computing Hardware Remains the Largest Category by Volume
Digital processing units (HTS 847150) retained their position as the single largest import category in the dataset, reaching $22.21 billion in February 2026 — up 9.49% from $20.29 billion in January. That $1.93 billion month-over-month increase is the largest in absolute dollar terms among all top movers.
Solid-state non-volatile semiconductor storage devices (HTS 852351) added $408.3 million, rising 16.29% to $2.91 billion. Automatic data processing storage units (HTS 847170) climbed 21.45% to $1.69 billion, adding $298.3 million. Across these three computing-related categories alone, February imports totaled roughly $26.8 billion — a figure that underscores just how dependent U.S. technology supply chains remain on imported hardware.
Commercial Vehicles Post Strong Gains
Two motor vehicle categories for goods transport both moved sharply higher. Light-duty spark-ignition trucks with a gross vehicle weight not over 5 metric tons (HTS 870431) rose 24.47% to $1.90 billion, adding $374.5 million. Heavier compression-ignition trucks over 5 metric tons (HTS 870422) jumped 90.64% to $601.1 million, adding $285.8 million.
Combined, commercial vehicle imports in these two categories totaled $2.51 billion in February, up from $1.85 billion in January. Fleet operators and logistics companies watching vehicle availability should note that this import acceleration may ease some of the supply tightness that has characterized the commercial truck market.
Petroleum Distillates Round Out the Top Ten
Light oils and preparations with greater than 70% petroleum or bituminous content (HTS 271012) rose 29.77% to $1.27 billion from $978.8 million, adding $291.4 million. The increase aligns with seasonal refinery demand patterns but also reflects ongoing U.S. reliance on imported feedstocks to supplement domestic refining capacity.
What This Data Signals for Supply Chains
The breadth of February's surge — spanning aerospace, pharmaceuticals, semiconductors, commercial vehicles, and energy — points to something more systematic than sector-specific demand. When unrelated industries accelerate imports simultaneously, the most common explanation is anticipatory buying ahead of expected cost increases, whether from tariffs, currency moves, or supply disruptions.
For procurement and logistics teams, the February data raises a practical question: if front-loading is driving these volumes, the months immediately following may see a demand air pocket as importers work through elevated inventories. Monitoring March and April figures will be critical to determining whether this surge represents genuine demand growth or a one-time pull-forward effect.
The pharmaceutical acceleration deserves particular attention. The combined $1.44 billion jump across immunological products, nucleic acids, and hormone-based dosage forms in a single month is unusual in both scale and breadth, and warrants close tracking as trade policy discussions around drug pricing and import duties continue.